Spanakis Elias, Gragnoli Claudia
Laboratory of Molecular Genetics of Complex and Monogenic Disorders, Division of Endocrinology, Diabetes and Metabolism, H044, Department of Medicine and Cellular and Molecular Physiology and Public Health Sciences, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.
Obes Surg. 2009 Sep;19(9):1333-4. doi: 10.1007/s11695-009-9888-5. Epub 2009 Jun 24.
Roux-en-Y gastric bypass (RYGBP) is the most commonly performed type of bariatric surgery, which is used in the treatment of obesity and type 2 diabetes. Recent case reports and case series have described a rare complication of RYGBP, status post-gastric-bypass hyperinsulinemic hypoglycemia, which was mainly managed successfully with pancreatectomy. In this letter, we describe the first successful management of status post-gastric-bypass hyperinsulinemic hypoglycemia with diazoxide.
Roux-en-Y胃旁路术(RYGBP)是最常施行的减肥手术类型,用于治疗肥胖症和2型糖尿病。最近的病例报告和病例系列描述了RYGBP一种罕见的并发症——胃旁路术后高胰岛素血症性低血糖症,其主要通过胰腺切除术成功治疗。在这封信中,我们描述了用二氮嗪首次成功治疗胃旁路术后高胰岛素血症性低血糖症的情况。